Search…

Lates News

12/05/2025

Hengrui Medicine: The board of directors has approved the relevant arrangements for the global offering of the company's H shares and listing on the Hong Kong Stock Exchange.

Latest

1 m ago

German Finance Minister: All partners agree that Germany playing a greater role in defense is the right thing to do.

2 m ago

With regards to the Daily Economic News report on May 12th, China Construction Bank Securities issued a research report giving Eastcompeace Technology Co., Ltd. (688700.SH) a buy rating. The rating reasons mainly include: 1) Pressure on the company's performance in 2024 due to downstream equipment demand in the new energy sector; 2) Improvement in revenue in the first quarter of 2025, but profits still under pressure due to depreciation and amortization; 3) Continued introduction of new products, waiting for downstream demand to be released.

2 m ago

White House officials: If the pharmaceutical industry does not make sufficient progress, the Health Secretary will implement most-favored-nation pricing through rulemaking.

2 m ago

Saudi Aramco: The company is in a favorable position, with a healthy financial condition and flexible capital, and will continue to fulfill its growth commitments and respond to any macroeconomic uncertainty.

2 m ago

Yueling Group (002725.SZ) receives a commitment letter for a special loan for stock repurchase of no more than 27 million yuan.

+852 - 60190728

Customer Support

Commercial Services